Suhong Daniel Kim is the Associate Director of Business Development at TiCARos, a clinical-stage biotech company in South Korea developing next-generation CAR-T and CAR-NK therapies. Daniel leads global partnering strategy, managing collaborations, licensing discussions, and strategic growth initiatives. He has been instrumental in advancing TiCARos’ proprietary CLIP and Converter platforms and promoting the company’s lead clinical asset, TC011. He holds a degree in Biotechnology from The George Washington University, where he developed a strong foundation in the intersection of science and business. Before joining TiCARos, Daniel held business development roles at other biotech firms, gaining experience in cross-border dealmaking and alliance management. Daniel has represented TiCARos at major international conferences such as BIO-Europe, BIO International Convention, and ChinaBio®. He has conducted company presentations more than 10 times at global bio conferences, introducing TiCARos’ technologies, pipeline, and partnership opportunities to a wide audience of biopharma stakeholders. With a focus on bridging science and strategy, Daniel is passionate about accelerating access to innovative therapies through global partnerships. He is especially committed to expanding TiCARos’ international presence and fostering collaborations across the US, EU, and Asia.